ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 136 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $120,246 | -61.2% | 122,700 | -45.0% | 0.00% | -100.0% |
| Q2 2023 | $310,248 | -35.8% | 223,200 | -26.5% | 0.00% | 0.0% |
| Q1 2023 | $482,883 | -76.2% | 303,700 | -6.6% | 0.00% | -83.3% |
| Q4 2022 | $2,025,373 | -15.7% | 325,100 | -9.3% | 0.01% | -14.3% |
| Q3 2022 | $2,402,000 | +57.2% | 358,570 | +49.2% | 0.01% | +40.0% |
| Q2 2022 | $1,528,000 | +232.9% | 240,300 | +143.0% | 0.01% | +400.0% |
| Q1 2022 | $459,000 | -75.6% | 98,900 | -73.7% | 0.00% | -85.7% |
| Q4 2021 | $1,882,000 | -52.3% | 376,249 | +14.8% | 0.01% | -50.0% |
| Q3 2021 | $3,948,000 | +729.4% | 327,724 | +1356.6% | 0.01% | +600.0% |
| Q2 2021 | $476,000 | -34.8% | 22,500 | -13.5% | 0.00% | -33.3% |
| Q1 2021 | $730,000 | -4.1% | 26,000 | -11.3% | 0.00% | 0.0% |
| Q4 2020 | $761,000 | -4.4% | 29,300 | +89.0% | 0.00% | -40.0% |
| Q2 2020 | $796,000 | +108.4% | 15,500 | +28.1% | 0.01% | +66.7% |
| Q1 2020 | $382,000 | -68.9% | 12,100 | -41.3% | 0.00% | -66.7% |
| Q4 2019 | $1,229,000 | +110.8% | 20,600 | +29.6% | 0.01% | +80.0% |
| Q3 2019 | $583,000 | +4.5% | 15,900 | +32.7% | 0.01% | 0.0% |
| Q2 2019 | $558,000 | -60.8% | 11,986 | -66.2% | 0.01% | -50.0% |
| Q1 2019 | $1,425,000 | -36.3% | 35,497 | -27.0% | 0.01% | -41.2% |
| Q4 2018 | $2,236,000 | +704.3% | 48,602 | +584.5% | 0.02% | +1600.0% |
| Q2 2018 | $278,000 | – | 7,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 2,629,835 | $116,685,000 | 25.08% |
| Aviva Holdings Ltd. | 1,200,100 | $53,248,000 | 14.21% |
| Boxer Capital, LLC | 1,375,000 | $61,009,000 | 6.77% |
| BB BIOTECH AG | 3,282,964 | $145,665,000 | 3.86% |
| Rhenman & Partners Asset Management AB | 353,961 | $15,705,000 | 1.57% |
| PFM Health Sciences, LP | 1,970,134 | $87,415,000 | 1.28% |
| Bellevue Group AG | 391,852 | $17,386,000 | 1.10% |
| Pentwater Capital Management LP | 2,351,500 | $104,336,000 | 0.88% |
| Partner Investment Management, L.P. | 25,440 | $1,129,000 | 0.86% |
| SABBY MANAGEMENT, LLC | 100,369 | $4,453,000 | 0.57% |